专题：Inflammatory Myopathies and Dermatomyositis

This cluster of papers covers the epidemiology, classification, and clinical features of inflammatory myopathies such as dermatomyositis and polymyositis. It includes discussions on autoantibodies, interstitial lung disease, cancer risk, treatment strategies, myositis-specific antibodies, juvenile dermatomyositis, and the association with malignancy.
最新文献
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

article Full Text OpenAlex

Crowned dens syndrome: a rare differential diagnosis of meningitis

letter Full Text OpenAlex

Development and Evaluation of the Dermatomyositis Outcomes for Muscle and Skin as an Outcome Measure in Dermatomyositis Clinical Trials

article Full Text OpenAlex

Successful diagnosis and treatment of canine polymyositis: utilizing MRI and immunohistochemistry for accurate detection

article Full Text OpenAlex

Statin-Induced Necrotizing Autoimmune Myopathy: Diagnosis and Treatment Approach

article Full Text OpenAlex

Nailfold videocapillaroscopy findings correlate with lung outcomes in idiopathic inflammatory myopathies–related interstitial lung disease

article Full Text OpenAlex

Age-Related Differences Between Juvenile and Adult Autoimmune Inflammatory Myopathies

article Full Text OpenAlex

Successful management of immunotherapy-resistant respiratory failure in anti-mitochondrial M2 antibody-positive myositis by modified lung volume recruitment therapy: A case report

article Full Text OpenAlex

Ultra-Orphan drug development for GNE Myopathy: A synthetic literature review and meta-analysis

review Full Text OpenAlex

Established and novel insights to guide cancer assessment in patients with idiopathic inflammatory myopathies

article Full Text OpenAlex

近5年高被引文献
Idiopathic inflammatory myopathies

review Full Text OpenAlex 565 FWCI73.5514356

New-onset IgG autoantibodies in hospitalized patients with COVID-19

article Full Text OpenAlex 434 FWCI102.44390664

Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial

article Full Text OpenAlex 231 FWCI47.88028843

Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial

article Full Text OpenAlex 225 FWCI30.81682137

Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin

article Full Text OpenAlex 223 FWCI29.70963018

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies

review Full Text OpenAlex 216 FWCI33.04214239

CD19-targeted CAR T cells in refractory antisynthetase syndrome

letter Full Text OpenAlex 210 FWCI73.08226006

Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial

article Full Text OpenAlex 193 FWCI27.67977967

CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome

article Full Text OpenAlex 180 FWCI62.84368257

Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

article Full Text OpenAlex 180 FWCI96.79441317